Psychedelic Sector

Psychedelics are a subcategory of psychotropics, which includes all psychoactive substances. Psychedelics are a hallucinogenic class of psychoactive drug whose primary action is to trigger psychedelic experiences via serotonin 2A receptor agonism, causing specific psychological, visual and auditory changes, and altered state of consciousness. Click on each companies to view:

  • Company Profiles
  • Easy view chart
  • Financials
  • Company News

Psychedelic Market Size

The psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD 6,859.95 million by 2027 from USD 2,077.90 million in 2019. (Full article)

Psychedelic Market Report (Canaccord)

CompanyRevenues ($)Cash ($)Total Assets ($)Total Liabilities ($)
Nutritional High3.11m0.7m16.8m26.6m
Champignon Brands0.32m1.5m14.1m75.1k
Yield Growth 0.13m7,0474.9m2.1m
Mind Medicine19.7m26.2m2.39m
Red Light Holland4.0m
Revive Therapeutics0.7m7.4m1.4m
NewLeaf Brands0.2m23.5m77.7k
Empower Clinics0.66m0.2m4.9m4.7m
Pharmadrug0.4m11.0m3.8m
Wuhan General Group25.0k136k793k
Hollister Biosciences
Mydecine Innovation
Numinus Wellness
New Wave Holdings
Duncan Park HoldingsPrivate PrivatePrivatePrivate
Updated June 1, 2020

Psychedelic News

Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market

Toronto, Ontario–(Newsfile Corp. – November 20, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland“), and Halo Labs Inc. (“Halo“) (NEO: HALO) (OTC: AGEEF) (Germany: A9KN) are pleased to announce they have entered into a non-binding letter of intent for the purposes of creating a joint venture to becomeContinue reading “Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market”

Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders

Open-label clinical trial will evaluate and refine best practices for the delivery of psilocybin-assisted psychotherapy for participants with tobacco, stimulant, alcohol, and/or opioid disorders VANCOUVER, BC, Nov. 18, 2020 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of solutions centred on the research, development, and delivery of safe, evidence-based, accessible psychedelic-assistedContinue reading “Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders”

PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform

TORONTO, Nov. 18, 2020 (GLOBE NEWSWIRE) — PharmaTher Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“PharmaTher”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce it has entered into an exclusive research collaboration agreement with Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA:Continue reading “PharmaTher Enters Into Research Collaboration with Revive Therapeutics for Psilocybin and panaceAI™ Psychedelic Discovery AI Platform”

Loading…

Something went wrong. Please refresh the page and/or try again.

Psychedelic Companies Listings